Drug Shortage Report for RIVA-LANSOPRAZOLE

Last updated on 2021-12-02 History
Report ID 95042
Drug Identification Number 02422816
Brand name RIVA-LANSOPRAZOLE
Common or Proper name Riva-Lansoprazole
Company Name LABORATOIRE RIVA INC.
Market Status MARKETED
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-09-30
Actual start date 2019-09-30
Estimated end date Unknown
Actual end date 2020-02-20
Shortage status Resolved
Updated date 2021-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 660 BOUL. INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-12-02 French Compare
v4 2021-12-02 English Compare
v3 2019-10-01 English Compare
v2 2019-09-30 French Compare
v1 2019-09-30 English Compare

Showing 1 to 5 of 5